Author

J. Linderberger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

C. Dash· 1 shared D. Christensen· 1 shared G. Downey· 1 shared G. Zhang· 1 shared H. Liu· 1 shared H. Waheed· 1 shared J. Kappler· 1 shared J. Liu· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

C. Dash

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HIV-1 preintegration complex preferentially integrates the viral DNA into nucleosomes containing trimethylated histone 3-lysine 36 modification

N. E. Sapp, N. Burge, K. Cox, S. Thapa, P. Prakash, M. Balasubramaniam, D. Christensen, M. Li, J. Linderberger, M. Kvaratskhelia, W. I. Sundquist, J. Pandhare, R. Craigie, M. G. Poirier, C. Dash

This study identifies that HIV-1 preintegration complex preferentially integrates viral DNA into nucleosomes with H3K36me3 modification and linker DNA.

bioRxiv · Feb 16, 2022 · PreprintBiochemistry

The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines

H. Liu, P. Wei, Q. Zhang, K. Aviszus, J. Linderberger, J. Yang, J. Liu, Z. Chen, H. Waheed, L. Reynoso, G. Downey, S. Frankel, J. Kappler, P. Marrack, G. Zhang

The paper compares vaccine efficacy against Delta and Lambda SARS-CoV-2 variants, finding Lambda has greater escape potential, with reduced antibody reactivity and therapeutic antibody binding.

bioRxiv · Aug 25, 2021 · PreprintImmunology